Key result
Acute kidney injury requiring hemodialysis was associated with a significantly higher in-hospital mortality rate of 53% compared to 34% in patients without AKI (OR 2.16).
Why the study?
Data were limited on acute kidney injury complicating acute myocardial infarction with cardiogenic shock.
Does the development of acute kidney injury (requiring or not requiring hemodialysis) increase in-hospital mortality and resource utilization in adult patients with acute myocardial infarction-related cardiogenic shock?
Cohort (n=440,257)
Yes
Does the development of acute kidney injury (requiring or not requiring hemodialysis) increase in-hospital mortality and resource utilization in adult patients with acute myocardial infarction-related cardiogenic shock?
Odds Ratio: 2.16 (95% CI 2.09–2.23)
Absolute Event Rate: 53% vs 34%
p-value: p=<0.001
AKI identifies higher-mortality AMI-CS patients; supports risk stratification but leaves causal prevention untested.
BACKGROUND: There are limited data on acute kidney injury (AKI) complicating acute myocardial infarction with cardiogenic shock (AMI-CS). This study sought to evaluate 15-year national prevalence, temporal trends and outcomes of AKI with no need for hemodialysis (AKI-ND) and requiring hemodialysis (AKI-D) following AMI-CS. METHODS: This was a retrospective cohort study from 2000-2014 from the National Inpatient Sample (20% stratified sample of all community hospitals in the United States). Adult patients (>18 years) admitted with a primary diagnosis of AMI and secondary diagnosis of CS were included. The primary outcome was in-hospital mortality in cohorts with no AKI, AKI-ND, and AKI-D. Secondary outcomes included predictors, resource utilization and disposition. RESULTS: During this 15-year period, 440,257 admissions for AMI-CS were included, with AKI in 155,610 (35.3%) and hemodialysis use in 14,950 (3.4%). Older age, black race, non-private insurance, higher comorbidity, organ failure, and use of cardiac and non-cardiac organ support were associated with the AKI development and hemodialysis use. There was a 2.6-fold higher adjusted risk of developing AKI in 2014 compared to 2000. Presence of AKI-ND and AKI-D was associated with a 1.3 and 1.7-fold higher adjusted risk of mortality. Compared to the cohort without AKI, AKI-ND and AKI-D were associated with longer length of stay (9±10, 12±13, and 18±19 days respectively; p<0.001) and higher hospitalization costs ($101,859±116,204, $159,804±190,766, and $265,875 ± 254,919 respectively; p<0.001). CONCLUSION: AKI-ND and AKI-D are associated with higher in-hospital mortality and resource utilization in AMI-CS.
No takes yet. Share an insight, caveat, or question.
Vallabhajosyula et al. (2019) conducted a cohort in Acute myocardial infarction with cardiogenic shock (AMI-CS) (n=440,257). Acute kidney injury requiring hemodialysis (AKI-D) vs. No acute kidney injury was evaluated on In-hospital mortality (OR 2.16, 95% CI 2.09-2.23, p=<0.001). Acute kidney injury requiring hemodialysis was associated with a significantly higher in-hospital mortality rate of 53% compared to 34% in patients without AKI (OR 2.16).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: